Table 1 Patient serum and CSF autoantibody NMDAR binding activity equivalent to activity of 502 Ab
From: Monoclonal humanized monovalent antibody blocking therapy for anti-NMDA receptor encephalitis
Equivalent binding activity as 502 Ab [µg/mL] | |||
|---|---|---|---|
Patient ID | Serum | CSF | CSF/Serum Ratio |
#1 | 2.2 | 0.15 | 6.8% |
#2 | ND | 0.0078 | ND |
#3 | 1.1 | 0.082 | 7.5% |
#4 | 0.65 | 0.078 | 12.0% |
#5 | 0.55 | 0.018 | 3.3% |
#6 | 0.56 | 0.015 | 2.7% |
#7 | 0.24 | 0.015 | 6.3% |
